Unique ID issued by UMIN | UMIN000041454 |
---|---|
Receipt number | R000047269 |
Scientific Title | Retinal laser photocoagulation to ameliorate choroidal congestion in central serous chorioretinopathy |
Date of disclosure of the study information | 2020/09/01 |
Last modified on | 2022/10/28 14:23:53 |
Retinal laser photocoagulation to ameliorate choroidal congestion in central serous chorioretinopathy
Retinal laser photocoagulation for central serous chorioretinopathy
Retinal laser photocoagulation to ameliorate choroidal congestion in central serous chorioretinopathy
Retinal laser photocoagulation for central serous chorioretinopathy
Japan |
Central serous chorioretinopathy
Ophthalmology |
Others
NO
Retinal laser photocoagulation in the macular area is a standard treatment for central serous chorioretinopathy. In the current study, we investigate the efficacy of additional retinal laser photocoagulation in the peripheral area with choroidal congestion to ameliorate the choroidal congestion leading to reduced choroidal thickness.
Safety,Efficacy
The reduction of central choroidal thickness 12 weeks after retinal laser photocoagulation.
The reduction of diameters of choroidal veins and absorption of serous retinal detachment 12 weeks after retinal laser photocoagulation.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
We perform retinal laser photocoagulation in the peripheral area showing choroidal congestion in addition to the macular area for all the participants.
20 | years-old | <= |
70 | years-old | > |
Male and Female
1) Having been diagnosed with central serous chorioretinopathy
2) Having no other fundus diseases
3) Having not received any treatments for central serous chorioretinopathy
4) Being an outpatient
5) Having given written consent to participate the current study
1) Showing dye leakage under the fovea or diffuse leakage in fluorescein angiography
2) Having received any steroid therapies
3) Having intraocular pressure of 21mmHg or more in the eye with central serous chorioretinopathy
4) Having been judged by doctors as inappropriate participants for the current study
20
1st name | Hideo |
Middle name | |
Last name | Akiyama |
Gunma University, School of Medicine
Ophthalmology
371-8511
3-39-15 Showa-machi, Maebashi, Gunma, 371-8511
027-220-8338
akiyamah4@gunma-u.ac.jp
1st name | Hidetaka |
Middle name | |
Last name | Matsumoto |
Gunma University, School of Medicine
Ophthalmology
371-8511
3-39-15 Showa-machi, Maebashi, Gunma, 371-8511
027-220-8338
hide-m@gunma-u.ac.jp
Gunma university hospital
Department of Ophthalmology, Gunma University, School of Medicine
Other
Institutional review board of Gunma university hospital
3-39-15 Showa-machi, Maebashi, Gunma, 371-8511
0272208740
gunmaciru-office@umin.ac.jp
NO
2020 | Year | 09 | Month | 01 | Day |
Unpublished
Preinitiation
2020 | Year | 08 | Month | 12 | Day |
2020 | Year | 08 | Month | 12 | Day |
2020 | Year | 09 | Month | 01 | Day |
2022 | Year | 09 | Month | 30 | Day |
2020 | Year | 08 | Month | 18 | Day |
2022 | Year | 10 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047269
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |